The CBO analysis found that the annual cost to cover these medications would be $5,600 per person on the drug in 2026, decreasing to $4,300 in 2034
Oral drops therapy that mimics natural GLP-1 to improve appetite control and metabolic efficiency
12 Other users describe an initial good result that then plateaus off relatively quickly
"In that situation, most people regret having taken the medication and wish that they had never heard of it because they're out the money and they are at the same weight or higher than when they started." For that reason, doctors like Persaud who treat obesity are glad generics are finally on the way though he says Canadians shouldn't have to wait until patents expire to access life-changing drugs like GLP-1s
Improved Health Lower your risk of heart disease, diabetes, and other chronic conditions
Why is Tirzepatide generally more expensive than Semaglutide